Skip to main content

Table 1 Patient characteristics

From: Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer

Patient

Gender

Age

Breast cancer

NACT /Response#

Breast surgery

Axillary surgery

Histology

Tumor Size (mm)

NHG

ER+

(%)

PR+

(%)

HER2

LVI

Positive

nodes

1

Female

72.4

Primary

Yes/Grade 2

Mastectomy

FNB- > ALND

Lobular

60

2

100

80

Neg

No

18

2

Female

86.1

Primary

No

Mastectomy

FNB- > ALND

Ductal

21

3

100

0

Neg

Yes

3

3

Female

40.5

Primary

No

Mastectomy

SNB- > ALND

Ductal

4

3

30

0

Pos

No

1

4

Female

45.3

Primary

Yes/Grade 5

BCS

FNB- > ALND

Ductal

0

3

15

0

Pos

No

0

5

Female

69.0

Primary

No

BCS

SNB- > ALND

Ductal

17

2

90

100

Neg

No

1

6

Female

70.0

Primary

No

Mastectomy

FNB- > ALND

Ductal

43

2

95

95

Pos

Yes

4

7

Female

66.3

Axillary recurrence

No

None

FNB- > ALND

Lobular

N/A

N/A

100

0

Neg

N/A

2

  1. ALND axillary lymph node dissection, BCS Breast conserving surgery, ER estrogen receptor, FNB fine needle biopsy, HER2 human epidermal growth factor receptor 2, LVI lymphovascular invasion, NACT neoadjuvant chemotherapy, NHG Nottingham histological grade, PR progesterone receptor, SNB sentinel node biopsy. #according to Miller-Payne criteria for grading response.